Lehrer Paul M, Karavidas Maria Katsamanis, Lu Shou-En, Feldman Jonathan, Kranitz Linda, Abraham Smrithy, Sanderson William, Reynolds Russ
UMDNJ - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
J Anxiety Disord. 2008 May;22(4):671-83. doi: 10.1016/j.janxdis.2007.07.001. Epub 2007 Jul 7.
We evaluated two protocols for treating adults with comorbid asthma and panic disorder. The protocols included elements of Barlow's panic control therapy and elements of Barlow's "panic control therapy" and several asthma education programs, as well as modules designed to teach participants how to differentiate asthma and panic symptoms, and how to apply specific home management strategies for each. Fifty percent of subjects dropped out of a 14-session protocol by the eighth session; however, 83% of patients were retained in an eight-session protocol. Clinical results were mostly equivalent: significant decreases of >50% in panic symptoms, clinically significant decreases in asthma symptoms, improvement in asthma quality of life, and maintenance of clinical stability in asthma. Albuterol use decreased significantly in the 14-session protocol and at a borderline level I the 8-session protocol, while pulmonary function was maintained. A controlled evaluation of this procedure is warranted.
我们评估了两种治疗合并哮喘和惊恐障碍的成人患者的方案。这些方案包括巴洛惊恐控制疗法的要素、巴洛“惊恐控制疗法”的要素以及几个哮喘教育项目,还有旨在教导参与者如何区分哮喘和惊恐症状,以及如何针对每种症状应用特定家庭管理策略的模块。在一个为期14节的方案中,50%的受试者在第八节时退出;然而,在一个为期八节的方案中,83%的患者坚持了下来。临床结果大多相当:惊恐症状显著下降超过50%,哮喘症状有临床意义的下降,哮喘生活质量得到改善,哮喘临床稳定性得以维持。在为期14节的方案中,沙丁胺醇的使用显著减少,在为期八节的方案中处于临界水平I,同时肺功能得以维持。有必要对该程序进行对照评估。